The Biopharmaceutical Industry's Annual Meeting - 600 Participants in Quebec
City

QUEBEC, Oct. 6 /CNW Telbec/ - The BioContact Quebec's symposium officially begins this morning at the Château Frontenac. For two days, this platform of discussions on the topic of "biopharmaceutical partnership" is a structured approach to personalised meetings between biopharmaceutical and pharmaceutical companies, universities, consulting firms, venture capital companies and government representatives.

This year, the 17th edition of BioContact Québec will give rise to an in-depth reflection on the new ways of doing things, both in medical research and in the development of medications and implementation of new partnership agreements. "In a world where economic stakes are high, where the parties involved are to face a reduction in the costs associated to the development of new drugs and health care in general, in a world where ethics, information management and constant arrival of new technologies will overcome the entire floor in the course of the next decades, there is no doubt that discussions will be of utmost interest during this 17th edition of BioContact Québec", concluded Martin Godbout.

Please note that, today at noon, BioContact Québec's guest speaker is Mr. David Nicholson, Ph.D, Sr VP, Worldwide Licensing and Knowledge Management, Merck Research Laboratories.

For further information: Hélène Turcotte, Pressroom Co-ordinator, BioContact Québec 2010, Telephone: [phone], [email protected]